Authors' reply to A. Winston, A. Cotter, M. Gisslen, P. W. G. Mallon and P. Cinque

Affiliations

¹ Service of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.
² Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital, Lausanne, Switzerland.

Free article

Comment

Kea Darling et al. HIV Med. 2020 Aug.

Free article

. 2020 Aug;21(7):e19-e20.

doi: 10.1111/hiv.12875. Epub 2020 May 18.

¹ Service of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.
² Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital, Lausanne, Switzerland.

No abstract available

Comment on

How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
Metral M, Nadin I, Locatelli I, Tarr PE, Calmy A, Kovari H, Brugger P, Cusini A, Gutbrod K, Schmid P, Schwind M, Kunze U, Di Benedetto C, Pignatti R, Du Pasquier R, Darling K, Cavassini M; Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study group, Swiss HIV Cohort Study. Metral M, et al. HIV Med. 2020 May;21(5):342-348. doi: 10.1111/hiv.12828. Epub 2019 Dec 27. HIV Med. 2020. PMID: 31883203 Free PMC article.
Response to: 'How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?'.
Winston A, Cotter A, Gisslen M, Mallon P, Cinque P. Winston A, et al. HIV Med. 2020 Aug;21(7):e17-e18. doi: 10.1111/hiv.12874. Epub 2020 May 22. HIV Med. 2020. PMID: 32441846 No abstract available.